biote Corp. (BTMD)

NGM – Real vaqt narxi. Valyuta: USD

1.79

-0.17 (-8.67%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

1.79

0.00 (0.00%)

Bozordan keyin: Jun 26, 2026, 4:31 PM EDT

01.06.2026

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj is a nationally recognized physician executive, board-certified OB/GYN and reproductive geneticist with more than two decades of experience spanning clinical practice, healthcare quality, academic medicine, innovation, and systems leadership. She joins Biote following senior leadership roles with.

28.05.2026

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced that Bob Peterson, Chief Financial Officer and Chief Business Officer, has been named Interim Chief Executive Officer and Director, effective June 8, 2026. Bret Christensen is stepping down from his role as Chief Executive Officer and will continue to serve on the Company's Board of Directors. In.

07.05.2026

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

06.05.2026

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago.

06.05.2026

Biote Reports First Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the first quarter ended March 31, 2026. “During the first quarter of 2026, we continued to advance our strategic priorities and remained focused on our key objective of restoring sustainable procedure revenue growth,” said Bret Christensen, Biote's Chief Executive Officer. “.

22.04.2026

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners' patients, today announced the Company will provide first quarter financial results on Wednesday, May 6, 2026, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conference call may be access.

12.03.2026

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Videolar

No Data

There is no data to display

Press-relizlar

01.06.2026

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

28.05.2026

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

06.05.2026

Biote Reports First Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the first quarter ended March 31, 2026. “During the first quarter of 2026, we continued to advance our strategic priorities and remained focused on our key objective of restoring sustainable procedure revenue growth,” said Bret Christensen, Biote's Chief Executive Officer. “.

11.03.2026

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the fourth quarter and full year ended December 31, 2025. “Over the past twelve months, Biote has focused on our strategic priorities which are designed to drive sustainable profitable growth and create long-term value for stockholders,” said Bret Christensen, Biote's Chief.

biote Corp. (BTMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

biote Corp. (BTMD)

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

Biote Reports First Quarter 2026 Financial Results

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reports First Quarter 2026 Financial Results

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

Biote Reports First Quarter 2026 Financial Results

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reports First Quarter 2026 Financial Results

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Search stocks

biote Corp. (BTMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

biote Corp. (BTMD)

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

Biote Reports First Quarter 2026 Financial Results

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reports First Quarter 2026 Financial Results

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

Biote Reports First Quarter 2026 Financial Results

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reports First Quarter 2026 Financial Results

Biote Reports Fourth Quarter and Full Year 2025 Financial Results